Excipients with specialized functions for effective drug delivery

Expert Opinion on Drug Delivery

Volumn 9, Issue 2, 2012, Pages 219-230

  Hamman, Josias ^a   Steenekamp, Jan ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

absorption enhancer; biopharmaceutics classification system; controlled release; multifunctional; pharmaceutical excipient

Indexed keywords

ATROPINE PLUS HYOSCYAMINE PLUS PHENOBARBITAL PLUS SCOPOLAMINE; BUFFER; CHELATING AGENT; CHITOSAN; CREMOPHOR; CYCLODEXTRIN; CYCLOSPORIN A; DIGOXIN; DRONABINOL; EXCIPIENT; LABRASOL; LIPID; LOPINAVIR PLUS RITONAVIR; LORATADINE; PENETRATIN; POLYSACCHARIDE; POLYSORBATE 40; POLYSORBATE 60; POLYSORBATE 80; PROGESTERONE; RAPAMYCIN; SESAME SEED OIL; SORBITAN LAURATE; SORBITAN OLEATE; SORBITAN PALMITATE; SORBITAN STEARATE; SORBITAN TRIOLEATE; STABILIZING AGENT; SURFACTANT;

DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; REVIEW;

ABSORPTION; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; DRUG CARRIERS; EXCIPIENTS; HUMANS; LIPIDS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PHOSPHOLIPIDS; SOLUBILITY; SOLVENTS; SURFACE-ACTIVE AGENTS;

EID: 84856108255     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.647907     Document Type: Review

References (105)

1. Airaksinen S, Karkalainen M, Kivikero N, et al. Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation. AAPS PharmSciTech 2005;6:E311-22
2. De Jong HJ. The safety of pharmaceutical excipients. Therapie 1999;54:11-14 (Pubitemid 29145965)
3. Baldrick P. Pharmaceutical Excipient development: the need for preclinical guidance. Regul Toxicol Pharmacol 2000;9:210-18
4. Fabiano V, Mameli C, Zuccoti GV. Paediatric pharmacology: remember the excipients. Pharmacol Res 2011;63:362-5
5. Builders PF, Bonaventure AM, Tisalade A, et al. Novel multifunctional pharmaceutical excipients derived from microcrystalline cellulose-starch microparticulate composites prepared by compatibilized reactive polymer blending. Int J Pharm 2010;388:159-67
6. Shaffer C. Reliable binders made new again by clever modification. Pharm Formulation Qual 2010;February/March:1-2
7. Robertson MI. Regulatory issues with excipients. Int J Pharm 1999;187:273-6
8. Moreton RC. Functionality and performance of excipients. Pharm Technol 2006;October:1-8
9. Apte SP, Ugwu SO. A review and classification of emerging excipients in parenteral medications. Pharm Technol 2003;27:46-60 (Pubitemid 37101917)
10. Deorkar N, Baker M. High functionality excipients: a review. Tablets Capsules 2008;6:22-7
11. Sonal SM, Jiny VK, Aneesh TP, et al. Emerging role of excipients in the pharmaceutical industry. Pharm Biol World 2008;August:63-6
12. Aungst BJ. Intestinal permeation enhancers. J Pharm Sci 2000;89:429-42
13. Whitehead K, Karr N, Mitragotri S. Safe and effective permeation enhancers for oral drug delivery. Pharm Res 2008;25:1782-8
14. Goole J, Lindley DJ, Roth W, et al. The effects of excipients on transporter mediated absorption. Int J Pharm 2010;393:17-31
15. Genazzani AA, Pattarino F. Difficulties in the production of identical drug products from pharmaceutical technology viewpoint. Drugs R D 2008;9:65-72 (Pubitemid 351311220)
16. Sharma P, Varma MVS, Chawla HPS, et al. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Il Farmaco 2005;60:874-83
17. Moeller EH, Jorgensen L. Alternative routes of administration for systemic delivery of protein pharmaceuticals. Drug Discov Today Technol 2008;5:e90-4
18. Majumdar S, Duvvuri S, Mitra AK. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development. Adv Drug Deliv Rev 2004;56:1437-52 (Pubitemid 38748825)
19. Johnson PH, Frank D, Constantino HR. Discovery of tight junction modulators: significance for drug development and delivery. Drug Discov Today 2008;13:261-7
20. Daugherty AL, Mrsny R. Transcellular uptake mechanisms of the intestinal epithelial barrier: part one. Pharm Sci Technol Today 1999;4:144-51 (Pubitemid 29195747)
21. Takayama K, Nakase I, Michiue H. Enhanced intracellular delivery using arginine-rich peptides by the addition penetration accelerating sequences (Pas). J Control Release 2009;138:128-33
22. Varma MVS, Ashokraj Y, Dey CS, Panchagnula R. P-glycoprotein inhibitors: and their screening: a perspective from bioavailability enhancement. Pharmacol Res 2003;48:347-59 (Pubitemid 36945333)
23. Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999;182:21-32 (Pubitemid 29229791)
24. Illum L, Farraj NF, Davis SS. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 1994;11:1186-9 (Pubitemid 24259861)
25. Sandri G, Rossi S, Bonferoni MC. Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternisation degree on absorption of high molecular weight molecule. Int J Pharm 2005;297:146-55 (Pubitemid 40720274)
26. Florea BI, Thanou M, Junginger HE, Borchard G. Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation. J Control Release 2006;110:353-61 (Pubitemid 41827489)
27. He W, Guo X, Zhang M. Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. Int J Pharm 2008;356:82-7
28. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-60 (Pubitemid 30326688)
29. Mohanachandran PS, Sindhumol PG, Kiran TS. Enhancement of solubility and dissolution rate: an overview. Pharm Globale Int J Compr Pharm 2010;1:1-10
30. Stegemann S, Leveiller F, Franchi D, et al. When poor solubility becomes an issue: from early stage to proof of concept. Eur J Pharm Sci 2007;31:249-61 (Pubitemid 47079001)
31. Chen LR, Wesley JA, Bhattachar S, et al. Dissolution behavior of a poorly water soluble compound in the presence of Tween 80. Pharm Res 2003;20:797-801 (Pubitemid 36515313)
32. Noyes AA, Whitney WR. The rate of solution of solids in their own solutions. J Am Chem Soc 1897;19:930-4
33. Lobenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000;50:3-12 (Pubitemid 30326685)
34. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201-30 (Pubitemid 38221966)
35. Crafts C, Baily B, Plante M, et al. Analysis of surfactants and excipients commonly used in pharmaceutical formulations: composition and lot-lot variability. 2010. Available from: http:// www.dionex.com/en-us/webdocs/85945- PO-Surfactants-Excipients-12March% 202010-LPN2450-01.pdf [Last accessed 30 August 2011]
36. Martin A. Physical pharmacy. LWW; Philadelphia: 1993
37. Patil SK, Wagh KS, Parik VB, et al. Strategies for solubility enhancement of poorly soluble drugs. IJPSRR 2011;8:74-80
38. Nema S, Washkuhn RJ, Brendel RJ. Excipients and their use in injectable products PDA. J Pharm Sci Technol 1997;51:166-71 (Pubitemid 28123757)
39. Kawakami K, Oda N, Myoshi K, et al. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents. Eur J Pharm Sci 2006;28:7-14
40. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29:278-87 (Pubitemid 44740131)
41. Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008;60:625-37
42. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000;11:S93-8
43. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173-82 (Pubitemid 38479922)
44. Bindu MB, Kusum B, Banji D. Novel strategies for poorly water soluble drugs. IJPSRR 2010;4:76-84
45. Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645-66 (Pubitemid 47299263)
46. Arun R, Ashok KCK, Sravanthi VVNSS. Cycodextrins as drug carrier molecule: a review. Sci Pharm 2008;76:567-98
47. Behera AL, Sahoo SK, Patil SV. Enhancement of solubility: a pharmaceutical overview. Der Pharm Lett 2010;2:310-18
48. Crowley PJ. Excipients as stabilizers. Pharm Sci Technol Today 1999;2:237-43 (Pubitemid 29272083)
49. Kerns EH, Di L. Pharmaceutical profiling in drug discovery. Drug Discov Today 2003;8:316-23 (Pubitemid 36332223)
50. Kalasz H, Antal I. Drug excipients. Curr Med Chem 2006;13:2535-63 (Pubitemid 44364155)
51. Pifferi G, Santoro P, Pedrani M. Quality and functionality of excipients. Il Farmaco 1999;54:1-14 (Pubitemid 29187013)
52. Freed AL, Strohmeyer HE, Mahjour M, et al. pH control of nucleophilic/ electrophilic oxidation. Int J Pharm 2008;357:180-8
53. Waterman KC, Adami RC, Alsante KM, et al. Stabilization of pharmaceuticals to oxidative degradation. Pharm Dev Technol 2002;7(1):32
54. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilisation and stabilization. J Pharm Sci 1996;85:1017-25 (Pubitemid 26338912)
55. Pandey S, Kumar B, Swami SMV, Gupta A. A review on pharmaceutical applications of cyclodextrins. Int J Pharm Technol 2010;2:281-319
56. Damian F, Fabian J, Friend DR, Kiser PF. Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions. Int J Pharm 2010;396:1-10
57. Torniainen K, Tammiletho S, Ulvi V. The effect of pH, buffer type and drug concentration on the photodegradation of ciprofloxacin. Int J Pharm 1996;132:53-61 (Pubitemid 26158711)
58. Nachaegari SK, Bansal AK. Coprocessed excipients for solid dosage forms. Pharm Tech 2004;January:52-64 (Pubitemid 38095734)
59. Luhn O, Fritzsching B. Smart excipients. Innovations Pharm Technol 2006;20:64-8
60. Korhonen O, Raatikainen P, Harjunen P, et al. Starch acetates - multifunctional direct compression excipients. Pharm Res 2000;17:1138-43
61. Beneke CE, Viljoen AM, Hamman JH. Polymeric plant-derived excipients in drug delivery. Molecules 2009;14:2602-20
62. Marwaha M, Sandhu D, Marwaha RK. Coprocessing of excipients: A review on excipient development for improved tabletting performance. Int J Appl Pharm 2010;2:41-7
63. Gohel MC. A review of co-processed directly compressible excipients. J Pharm Pharm Sci 2005;8:76-93 (Pubitemid 41528873)
64. Akram M, Naqvi SBS, Gauhar S. Development of co-processed microgranules for direct compression. Int J Pharm Pharm Sci 2011;3:64-9
65. Ayyappan J, Umapathi P, Darlin Q. Development and evaluation of a directly compressible co-processed multifunction sustained release agent for tablets. Int J Pharm Pharm Sci 2010;2:201-5
66. Goyanes A, Souto C, Martinez-Pacheco R. Co-processed MCC-Eudragit E excipients for extrusion-spheronization. Eur J Pharm Biopharm 2011;published online 13 July 2011; doi:10.1016/j.ejpb.2011.07.013
67. Rashid I, Al-Remawi M, Leharne SA, et al. A novel multifunctional pharmaceutical excipient: Modification of the permeability of starch by processing with magnesium silicate. Int J Pharm 2011;411:18-26
68. Riis T, Bauer-Brandl A, Wagner T, Kranz H. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations. Eur J Pharm Biopharm 2007;65:78-84 (Pubitemid 44827687)
69. Pillai O, Panchagnula R. Polymers in drug delivery. Curr Opin Chem Biol 2001;5:447-51 (Pubitemid 32900518)
70. Avachat A, Kotwal V. Design and evaluation of matrix based controlled release tablets of diclofenac sodium and chondroitin sulphate. AAPS PharmSciTech 2007;8:E1-6
71. Talukdar MM, Kinget R. Swelling and drug release behavior of xanthan gum matrix tablets. Int J Pharm 1995;120:63-72
72. Shilpa A, Agrawal SS, Ray AR. Controlled delivery of drugs from alginate matrix. J Macromol Sci C Polymer Rev 2003;C43:187-221
73. Durig T, Fassihi R. Guar-based monolithic systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics. J Control Release 2002;80:45-56 (Pubitemid 34273747)
74. Nabais T, Brouillet F, Kyriacos S, et al. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2007;65:371-8
75. Llabot JM, Manzo RH, Allemandi DA. Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. Int J Pharm 2004;276:59-66 (Pubitemid 38542988)
76. Sriamornsak P, Thirawong N, Weerapol Y, et al. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm 2007;67:211-19 (Pubitemid 46991322)
77. Bhise KS, Dhumal RS, Chauhan B, et al. Effect of oppositely charged polymer and dissolution medium on swelling erosion and drug release from chitosan matrices. AAPS PharmSciTech 2007;8:E1-9 (Pubitemid 47007411)
78. Park S-H, Chun M-K, Choi H-K. Preparation of an extended release matrix tablet using chitosan/Carbopol interpolymer complex. Int J Pharm 2008;347:39-44 (Pubitemid 350180315)
79. Moustafine RI, Salachova AR, Frolova ES, et al. Interpolyelectrolyte complexes of Eudragit EPO with sodium alginate as potential carriers for colonic drug delivery: monitoring of structural transformation and composition changes during swellability and release evaluating. Drug Dev Ind Pharm 2009;35:1439-51
80. Andreopoulus AG, Tarantili PA. Study of biopolymers as carriers for controlled release. J Macromol Sci Phys 2002;41:559-78 (Pubitemid 34789822)
81. Bajpai AK, Shukla SK, Bhanu S, et al. Responsive polymers in controlled drug delivery. Prog Polym Sci 2008;33:1088-118
82. Traitel T, Goldbart R, Kost J. Smart polymers for responsive drug-delivery systems. J Biomater Sci Polymer Ed 2008;19:755-67 (Pubitemid 351820781)
83. Vasile C, Dumitriu RP, Cheaburu CN, Oprea AM. Architecture and composition influence on he properties of some smart polymeric materials designed as matrices in drug delivery systems. Appl Surface Sci 2009;256S:S65-71
84. Kim S, Kim J-H, Jeon O, et al. Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm 2009;71:420-30
85. Udata C, Patel J, Pal D, et al. Enhanced transport of a novel anti-HIV agent - cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers. Int J Pharm 2003;250:157-68 (Pubitemid 35447946)
86. Kamm W, Jonczyk A, Jung T, et al. Evaluation of absorption enhancement for a potent cyclopeptidic alphanubeta3-antagonist in a human intestinal cell line (Caco-2). Eur J Pharm Sci 2000;10:205-14 (Pubitemid 30190096)
87. Sharma P, Varma MVS, Chawla HPS, et al. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Il Farmaco 2005;60:884-93 (Pubitemid 41586262)
88. Takatsuka S, Morita T, Horikiri Y, et al. Absorption enhancement of poorly absorbed hydrophilic compounds from various mucosal sites by combination of mucolytic agent and non-ionic surfactant. Int J Pharm 2007;338:87-93 (Pubitemid 46777222)
89. Alani AWG, Robinson JR. Mechanistic understanding of oral drug absorption enhancement of chromolyn sodium by an amino acid derivative. Pharm Res 2007;25:48-54
90. Salama NN, Fasano A, Thakar M, Eddington ND. The impact of DeltaG on the oral bioavailability of low bioavailable therapeutic agents. J Pharmacol Exp Ther 2004;312:199-205
91. Tirumalasetty PP, Eley JG. Evaluation of dodecylmaltoside as a permeability enhancer of insulin using human carcinoma cells. J Pharm Sci 2005;94:246-55 (Pubitemid 40293322)
92. Shah P, Jogani V, Mishra P, et al. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers. J Pharm Sci 2007;96:2710-22 (Pubitemid 47597820)
93. Tuesca A, Nakamura K, Morishita M, et al. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy. J Pharm Sci 2008;97:2607-18
94. Maher S, Kennelly R, Bzik VA, et al. Evaluation of intestinal absorption enhancement and localmucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae. Eur J Pharm Sci 2009;38:291-300
95. Chen W, Lu Z, Viljoen AM, Hamman JH. Intestinal drug transport enhancement by Aloe vera. Planta Med 2009;75:587-95
96. Lu Z, Chen W, Viljoen A, Hamman J. Effect of sinomenine on the in vitro intestinal epithelial transport of selected compounds. Phytother Res 2010;24:211-18
97. Alsenz J, Russell-Jones GJ, Westwood S, et al. Oral absorption of peptides through the cobalamin (vitamin B12) pathway in the rat intestine. Pharm Res 2000;17:825-32 (Pubitemid 30666963)
98. Friedrichsen GM, Nielsen CU, Steffansen B, Begtrup M. Model prodrugs designed for the intestinal peptide transporter. A synthetic approach for coupling of hydroxyl-containing compounds to dipeptides. Eur J Pharm Sci 2001;14:13-19 (Pubitemid 32655410)
99. Kidron M, Dinh S, Menachem A, et al. A novel peroral insulin formulation: proof of concept study in non-diabetic subjects. Diabet Med 2003;21:354-7 (Pubitemid 38519671)
100. Khafagy ES, Morishita M, Kamei N, et al. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins. Int J Pharm 2009;381:49-55
101. Kamei N, Morishita M, Kanayama Y, et al. Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography. J Control Release 2010;146:16-22
102. Nerurkar MM, Ho NFH, Burton PS, et al. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. J Pharm Sci 1997;86:813-21 (Pubitemid 27297493)
103. Iqbal J, Hombach J, Matuszczak B, Bernkop-Schnurch A. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor. J Control Release 2010;147:62-9
104. Amidon GL, Lennernas H, Shah V, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of the in vitro drug productdissolution and in vivo bioavailability. Pharm Res 1995;12:413-20
105. Florence AT, Attwood D. Physicochemical principles of pharmacy. PhP; London: 2006